OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT02554474
Collaborator
Simon Fraser University (Other), Arthritis Research Centre of Canada (Other), Vancouver General Hospital (Other), The Arthritis Society, Canada (Other), Fraser Health (Other)
118
1
2
31.7
3.7

Study Details

Study Description

Brief Summary

Being physically active can reduce pain and fatigue, improve mobility and enhance quality of life in people with arthritis, but adherence to an active lifestyle is poor, with less than half of people with arthritis being active. The primary goal of this randomized controlled trial is to assess the efficacy of a physical activity coaching model to improve physical activity participation and reduce sedentary time in patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus. This model combines the use of a Fitbit Flex (wireless physical activity tracker) paired with a FitViz application, a group education session, and telephone counselling by a physiotherapist.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Education, Fitbit/FitViz, physiotherapist counselling.
  • Behavioral: Same intervention with a 9-week delay
N/A

Detailed Description

Patient self-management is a fundamental component in arthritis care that is often neglected. Physical activity is an essential part of self-management, however, less than half of people with arthritis are active. There are several factors that are associated with low physical activity participation such as motivation, doubts about the effectiveness of prescribed exercises, and lack of health professional advice on ways to progress physical activity. The variety of risk factors highlights the need for a multifaceted approach that provides support in terms of knowledge, skill development and timely advice from health professionals, as well as motivational support to stay active.

Our primary objective is to assess the efficacy of a physical activity counselling model, involving the use of a Fitbit Flex (wireless physical activity tracker) paired with a FitViz application (app), a group education session, and telephone counselling by a physiotherapist, to improve physical activity participation in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Our secondary objective is to assess the effect of the intervention on reducing patients' sedentary time, and improving fatigue, mood, pain, and self-efficacy in arthritis management. We will carry out three aims: 1) To develop the FitViz app to pair with Fitbit to enhance user experience, 2) To conduct a pilot test for the Fitbit/FitViz intervention, 3) To evaluate the effect of the physical activity coaching model in patients with RA and SLE. In this proof-of-concept randomized controlled trial (RCT), the investigators hypothesize that compared to a control group (i.e. the Delayed Intervention group), participants in the Immediate Intervention Group will 1) increase moderate/vigorous physical activity (MVPA), 2) reduce sedentary time, 3) improve in fatigue, mood, and pain levels, and 4) improve in their self-efficacy in disease management.

The investigators will use a mixed-methods approach, involving a RCT and in-depth interviews. The proof-of-concept study will employ a stepped wedge RCT design, whereby the intervention will be sequentially rolled out to participants over a number of time periods. The order in which individuals receive the intervention will be determined at random. The strength of this design is that it can properly address the efficacy question, while avoiding the dilemma of withholding the intervention to some participants, as in a parallel group design.

Study Design

Study Type:
Interventional
Actual Enrollment :
118 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effective of Online Physical Activity Monitoring in Inflammatory Arthritis (OPAM-IA): A New Model of Care
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Aug 25, 2019
Actual Study Completion Date :
Aug 25, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Immediate Group

Time spent in Moderate/Vigorous Physical Activity (MVPA) was measured with a SenseWear Mini sensor over a 7-day period. The mean time was calculated in bouted MVPA per day. A bout is defined as >= 10 consecutive minutes or more at the level of >= 3 METs (i.e., the lower bound of MVPA), with allowance for interruption of up to two minutes below the threshold.

Behavioral: Education, Fitbit/FitViz, physiotherapist counselling.
Participants will receive a brief education session, use a physical activity tracker Fitbit Flex with paired with a FitViz app, and remote counseling by a PT. Intervention will be received immediately.

Placebo Comparator: Delay Group

Time spent in sedentary activity was measured with a SenseWear Mini sensor over a 7-day period. The mean daily time spent in sedentary activity was calculated with an energy expenditure of <=1.5 METs, occurring in bouts of >= 20 minutes during waking hours.

Behavioral: Same intervention with a 9-week delay
The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 9-week delay.

Outcome Measures

Primary Outcome Measures

  1. Daily Time in Moderate/Vigorous Physical Activity [Baseline, 9 weeks, 18 weeks, 27 weeks]

    Time spent in Moderate/Vigorous Physical Activity (MVPA) was measured with a SenseWear Mini sensor over a 7-day period. The mean time was calculated in bouted MVPA per day. A bout is defined as >= 10 consecutive minutes or more at the level of >= 3 METs (i.e., the lower bound of MVPA), with allowance for interruption of up to two minutes below the threshold.

Secondary Outcome Measures

  1. Time Spent in Sedentary Activity [Baseline, 9 weeks, 18 weeks, 27 weeks]

    Time spent in sedentary activity was measured with a SenseWear Mini sensor over a 7-day period. The mean daily time spent in sedentary activity was calculated with an energy expenditure of <=1.5 METs, occurring in bouts of >= 20 minutes during waking hours.

  2. Fatigue Severity Scale [Baseline, 9 weeks, 18 weeks, 27 weeks]

    The Fatigue Severity Scale consists of 9 questions and measures the impact of fatigue. A total score is calculated by averaging the rating from each question. Range 1-7; lower score = less fatigue.

  3. McGill Pain Questionnaire Short Form (MPQ-SF) [Baseline, 9 weeks, 18 weeks, 27 weeks]

    The MPQ-SF contains 15 pain-related words, which can be rated from 0 to 3. Range 0 - 45; higher=more severe pain.

  4. The Patient Health Questionnaire-9 (PHQ-9) [Baseline, 9 weeks, 18 weeks, 27 weeks]

    The PHQ-9 consists of nine questions (rated from 0 to 3) that correspond to nine diagnostic criteria for major depressive disorder. Range 0-27; lower score = less depressive symptoms),

  5. Partners In Health Scale [Baseline, 9 weeks, 18 weeks, 27 weeks]

    The Partners in Health Scale is a 12-item measure designed to assess self-efficacy, knowledge of health conditions and treatment, and self-management behaviors such as adopting a healthy lifestyle. Range 0-96; higher score = higher perceived confidence and ability in self-care.

  6. The Self-Reported Habit Index (SRHI) - Sitting at Work Index [Baseline, 9 weeks, 18 weeks, 27 weeks]

    The SRHI is a 12-item scale, rated on a 7-point Likert scale, that measures characteristics of habitual behavior. Participants rated their strength of habit of sitting at work. A higher score indicates a stronger habit or behavior that is done frequently, automatically, and done without thinking about it. Range 1-7; higher score = stronger habit.

  7. The Self-Reported Habit Index (SRHI) - Sitting at Leisure Index [Baseline, 9 weeks, 18 weeks, 27 weeks]

    The SRHI is a 12-item scale, rated on a 7-point Likert scale, that measures characteristics of habitual behavior. Participants rated their strength of habit of sitting at leisure. A higher score indicates a stronger habit or behavior that is done frequently, automatically, and done without thinking about it. Range 1-7; higher score = stronger habit.

  8. The Self-Reported Habit Index (SRHI) - Walking Index [Baseline, 9 weeks, 18 weeks, 27 weeks]

    The SRHI is a 12-item scale, rated on a 7-point Likert scale, that measures characteristics of habitual behavior. Participants rated their strength of walking habit. A higher score indicates a stronger habit or behavior that is done frequently, automatically, and done without thinking about it. Range 1-7; higher score = stronger habit.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Have a physician confirmed diagnosis of RA or SLE.

  • Have an email address and daily access to a computer with internet connection.

  • Be able to attend a 1.5-hour education session at Mary Pack Arthritis Centre, Arthritis Research Centre, or a Fraser Health site.

Exclusion Criteria:
  • Have previously used any physical activity wearables.

  • Face a level of risk by exercising as identified by the Physical Activity Readiness Questionnaire (PAR-Q).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Arthritis Research Canada Richmond British Columbia Canada V6X 2C7

Sponsors and Collaborators

  • University of British Columbia
  • Simon Fraser University
  • Arthritis Research Centre of Canada
  • Vancouver General Hospital
  • The Arthritis Society, Canada
  • Fraser Health

Investigators

  • Principal Investigator: Linda Li, PhD, Professor

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Linda Li, Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT02554474
Other Study ID Numbers:
  • H15-01843
First Posted:
Sep 18, 2015
Last Update Posted:
Jun 21, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Linda Li, Professor, University of British Columbia
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details Recruitment period was 2017-2019. Participants were recruited from the Mary Pack Arthritis Program (Vancouver Coastal Health Authority) and Fraser Health Authority in British Columbia, Canada. Study information was also posted on Facebook, Twitter, Kajiji and Craigslist.
Pre-assignment Detail After completing baseline measures at home, participants were randomized to the Immediate or Delay Group in 1:1 allocation ratio.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components will be delivered to the participants in Months 1 and 2. The session will include a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants will use the Fitbit/FitViz. The PT will review the progress with participants via bi-weekly phone calls and progressively modify their activities. In Month 3-6, participants will continue using the Fitbit/FitViz and have access to a PT via email as needed, but no bi-weekly phone calls. Education, Fitbit/FitViz, physiotherapist counselling.: Participants will receive a brief education session, use a physical activity tracker Fitbit Flex with paired with a FitViz app, and remote counseling by a PT. Intervention will be received immediately. Same intervention with a 2 month delay: The full intervention will be initiated in Month 3 and 4 with a brief education session, use of a Fitbit paired with the FitViz app, and counseling by a PT. In Month 5-6, participants will continue the intervention without the PT phone calls, but will have email access to PT, if needed. Same intervention with a 2 month delay: The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 2 month delay.
Period Title: Overall Study
STARTED 59 59
COMPLETED 56 57
NOT COMPLETED 3 2

Baseline Characteristics

Arm/Group Title Immediate Group Delay Group Total
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Total of all reporting groups
Overall Participants 59 59 118
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
53.5
(14.7)
53.1
(12.6)
53.3
(13.6)
Sex: Female, Male (Count of Participants)
Female
51
86.4%
54
91.5%
105
89%
Male
8
13.6%
5
8.5%
13
11%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (participants) [Number]
Canada
59
100%
59
100%
118
100%
Region of Enrollment (participants) [Number]
Canada
59
100%
59
100%
118
100%
Daily time in moderate/vigorous physical activity (Minutes) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Minutes]
37.8
(39.6)
31.6
(42.7)
34.7
(41.1)
Time in purposeful activity (Minutes) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Minutes]
13.0
(20.4)
11.2
(24.5)
12.1
(22.5)
Daily steps (Steps) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Steps]
5900.8
(3214.1)
5605.7
(2865.1)
5753.2
(3035.2)
Daily sedentary time (Minutes) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Minutes]
491.6
(192.5)
523.0
(194.4)
507.3
(193.3)
McGill Pain Questionnaire (Units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Units on a scale]
13.3
(10.8)
13.9
(9.5)
13.6
(10.1)
Fatigue Severity Scale (Units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Units on a scale]
4.8
(1.4)
4.9
(1.3)
4.8
(1.3)
Partners in Health (Units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Units on a scale]
72.8
(11.7)
73.5
(12.2)
73.1
(11.9)
Patient Health Questionnaire (PHQ-9) (Units on a scale) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Units on a scale]
7.6
(5.9)
8.1
(5.6)
7.8
(5.7)
Self-Reported Habit Index (units on a scale) [Mean (Standard Deviation) ]
Sitting at work subscale
4.5
(1.7)
4.6
(1.8)
4.5
(1.7)
Sitting at leisure subscale
4.7
(1.4)
4.7
(1.3)
4.7
(1.3)
Walking subscale
4.1
(1.8)
3.7
(1.6)
3.9
(1.7)

Outcome Measures

1. Primary Outcome
Title Daily Time in Moderate/Vigorous Physical Activity
Description Time spent in Moderate/Vigorous Physical Activity (MVPA) was measured with a SenseWear Mini sensor over a 7-day period. The mean time was calculated in bouted MVPA per day. A bout is defined as >= 10 consecutive minutes or more at the level of >= 3 METs (i.e., the lower bound of MVPA), with allowance for interruption of up to two minutes below the threshold.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
37.8
(39.6)
31.6
(42.7)
9 weeks
44.7
(41.2)
31.6
(32.4)
18 weeks
43.2
(48.2)
32.8
(36.8)
27 weeks
37.8
(38.8)
34.0
(36.1)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, we used analysis of covariance (ANCOVA) to estimate an adjusted mean difference comparing time in MVPA at 9 weeks (primary end point) between groups, adjusting for baseline MVPA, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value 9.4
Confidence Interval (2-Sided) 95%
-0.5 to 19.3
Parameter Dispersion Type:
Value:
Estimation Comments
2. Secondary Outcome
Title Time Spent in Sedentary Activity
Description Time spent in sedentary activity was measured with a SenseWear Mini sensor over a 7-day period. The mean daily time spent in sedentary activity was calculated with an energy expenditure of <=1.5 METs, occurring in bouts of >= 20 minutes during waking hours.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
491.6
(192.5)
523.0
(194.4)
9 weeks
508.4
(203.5)
530.0
(180.2)
18 weeks
507.8
(195.8)
531.4
(165.4)
27 weeks
506.8
(179.7)
498.0
(155.6)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, we used analysis of covariance (ANCOVA) to estimate an adjusted mean difference comparing sedentary time at 9 weeks (primary end point) between groups, adjusting for baseline sedentary time, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value -10.4
Confidence Interval (2-Sided) 95%
-53.4 to 32.6
Parameter Dispersion Type:
Value:
Estimation Comments
3. Secondary Outcome
Title Fatigue Severity Scale
Description The Fatigue Severity Scale consists of 9 questions and measures the impact of fatigue. A total score is calculated by averaging the rating from each question. Range 1-7; lower score = less fatigue.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
4.8
(1.4)
4.9
(1.3)
9 weeks
4.5
(1.3)
4.9
(1.3)
18 weeks
4.8
(1.3)
4.6
(1.5)
27 weeks
4.5
(1.4)
4.7
(1.4)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, we used analysis of covariance (ANCOVA) to estimate an adjusted mean difference comparing time in the Fatigue Severity Scale at 9 weeks (primary end point) between groups, adjusting for baseline fatigue score, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value -0.31
Confidence Interval (2-Sided) 95%
-0.63 to 0.01
Parameter Dispersion Type:
Value:
Estimation Comments
4. Secondary Outcome
Title McGill Pain Questionnaire Short Form (MPQ-SF)
Description The MPQ-SF contains 15 pain-related words, which can be rated from 0 to 3. Range 0 - 45; higher=more severe pain.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
13.3
(10.8)
13.9
(9.5)
9 weeks
10.9
(8.4)
14.6
(9.7)
18 weeks
10.6
(9.6)
12.6
(10.0)
27 weeks
11.8
(10.0)
11.0
(9.8)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, we used analysis of covariance (ANCOVA) to estimate an adjusted mean difference comparing pain at 9 weeks (primary end point) between groups, adjusting for pain score, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value -2.45
Confidence Interval (2-Sided) 95%
-4.78 to -0.13
Parameter Dispersion Type:
Value:
Estimation Comments
5. Secondary Outcome
Title The Patient Health Questionnaire-9 (PHQ-9)
Description The PHQ-9 consists of nine questions (rated from 0 to 3) that correspond to nine diagnostic criteria for major depressive disorder. Range 0-27; lower score = less depressive symptoms),
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
7.6
(5.9)
8.1
(5.6)
9 weeks
6.8
(5.6)
7.9
(5.7)
18 weeks
6.0
(5.0)
6.2
(5.4)
27 weeks
5.2
(3.8)
6.7
(5.9)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, we used analysis of covariance (ANCOVA) to estimate an adjusted mean difference comparing the PHQ-9 scores at 9 weeks (primary end point) between groups, adjusting for baseline score, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value -0.22
Confidence Interval (2-Sided) 95%
-1.78 to 1.35
Parameter Dispersion Type:
Value:
Estimation Comments
6. Secondary Outcome
Title Partners In Health Scale
Description The Partners in Health Scale is a 12-item measure designed to assess self-efficacy, knowledge of health conditions and treatment, and self-management behaviors such as adopting a healthy lifestyle. Range 0-96; higher score = higher perceived confidence and ability in self-care.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
72.8
(11.7)
73.5
(12.2)
9 weeks
75.5
(12.5)
74.6
(11.2)
18 weeks
77.7
(11.4)
78.7
(10.8)
27 weeks
77.9
(12.6)
77.4
(10.7)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, we used analysis of covariance (ANCOVA) to estimate an adjusted mean difference comparing the Partners In Health Scale scores at 9 weeks (primary end point) between groups, adjusting for baseline score, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value 1.58
Confidence Interval (2-Sided) 95%
-1.02 to 4.18
Parameter Dispersion Type:
Value:
Estimation Comments
7. Secondary Outcome
Title The Self-Reported Habit Index (SRHI) - Sitting at Work Index
Description The SRHI is a 12-item scale, rated on a 7-point Likert scale, that measures characteristics of habitual behavior. Participants rated their strength of habit of sitting at work. A higher score indicates a stronger habit or behavior that is done frequently, automatically, and done without thinking about it. Range 1-7; higher score = stronger habit.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
4.5
(1.7)
4.6
(1.8)
9 weeks
4.3
(1.8)
4.7
(1.7)
18 weeks
4.6
(1.7)
4.6
(1.8)
27 weeks
4.4
(1.4)
4.6
(1.7)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, analysis of covariance (ANCOVA) was used to estimate an adjusted mean difference comparing the Sitting at Work index scores at 9 weeks (primary end point) between groups, adjusting for baseline score, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value 0.05
Confidence Interval (2-Sided) 95%
-0.05 to 0.16
Parameter Dispersion Type:
Value:
Estimation Comments
8. Secondary Outcome
Title The Self-Reported Habit Index (SRHI) - Sitting at Leisure Index
Description The SRHI is a 12-item scale, rated on a 7-point Likert scale, that measures characteristics of habitual behavior. Participants rated their strength of habit of sitting at leisure. A higher score indicates a stronger habit or behavior that is done frequently, automatically, and done without thinking about it. Range 1-7; higher score = stronger habit.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
4.7
(1.4)
4.7
(1.3)
9 weeks
4.7
(1.3)
4.8
(1.4)
18 weeks
4.6
(1.3)
4.8
(1.2)
27 weeks
4.6
(1.3)
4.7
(1.4)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, analysis of covariance (ANCOVA) was used to estimate an adjusted mean difference comparing the Sitting at Leisure index scores at 9 weeks (primary end point) between groups, adjusting for baseline score, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value 0
Confidence Interval (2-Sided) 95%
-0.37 to 0.37
Parameter Dispersion Type:
Value:
Estimation Comments
9. Secondary Outcome
Title The Self-Reported Habit Index (SRHI) - Walking Index
Description The SRHI is a 12-item scale, rated on a 7-point Likert scale, that measures characteristics of habitual behavior. Participants rated their strength of walking habit. A higher score indicates a stronger habit or behavior that is done frequently, automatically, and done without thinking about it. Range 1-7; higher score = stronger habit.
Time Frame Baseline, 9 weeks, 18 weeks, 27 weeks

Outcome Measure Data

Analysis Population Description
59 participants were randomized into each group. Week 9: Immediate Group - 3 withdrew;1 with missing data. Delay Group - 2 withdrew Week 18: Immediate Group - 3 additional participants withdrew; 2 with missing data. Delay Group - 1 additional participant withdrew. Week 27: Immediate Group - 1 additional participants withdrew, Delay Group - no additional participant withdrew; 6 with missing data.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Education, Fitbit/FitViz, physiotherapist counselling. These 3 components were delivered to the participants in Weeks 1-8. The session included a short presentation about physical activity in everyday life, an individual goal-setting session with a registered PT, and an orientation to the Fitbit and FitViz app. Participants used a Fitbit and the FitViz app. The PT reviewed the progress with participants via bi-weekly counselling phone calls and progressively modify their activities. In Weeks 9-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls. Same intervention (Education, Fitbit/FitViz, physiotherapist counselling) with a 9-week delay. The full intervention was delivered in Week 10-17. In Weeks 18-26, participants continued using the Fitbit and FitViz and had access to a PT via email as needed, but no bi-weekly phone calls.
Measure Participants 59 59
Baseline
4.1
(1.8)
3.7
(1.6)
9 weeks
4.4
(1.7)
3.6
(1.7)
18 weeks
4.3
(1.6)
4.0
(1.6)
27 weeks
4.7
(1.5)
4.0
(1.7)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Immediate Group, Delay Group
Comments We performed an intent-to-treat analysis. For the main comparison, analysis of covariance (ANCOVA) was used to estimate an adjusted mean difference comparing the Walking index scores at 9 weeks (primary end point) between groups, adjusting for baseline score, diagnosis, and blocking.
Type of Statistical Test Superiority
Comments
Statistical Test of Hypothesis p-Value
Comments
Method
Comments
Method of Estimation Estimation Parameter Adjusted difference in mean change
Estimated Value 0.54
Confidence Interval (2-Sided) 95%
0.08 to 0.99
Parameter Dispersion Type:
Value:
Estimation Comments

Adverse Events

Time Frame 26 weeks
Adverse Event Reporting Description Self-reported adverse events were collected, including muscle pain, ligament sprain, or falls while being physically active, were collected.
Arm/Group Title Immediate Group Delay Group
Arm/Group Description Time spent in Moderate/Vigorous Physical Activity (MVPA) was measured with a SenseWear Mini sensor over a 7-day period. The mean time was calculated in bouted MVPA per day. A bout is defined as >= 10 consecutive minutes or more at the level of >= 3 METs (i.e., the lower bound of MVPA), with allowance for interruption of up to two minutes below the threshold. Time spent in sedentary activity was measured with a SenseWear Mini sensor over a 7-day period. The mean daily time spent in sedentary activity was calculated with an energy expenditure of <=1.5 METs, occurring in bouts of >= 20 minutes during waking hours.
All Cause Mortality
Immediate Group Delay Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/59 (0%) 0/59 (0%)
Serious Adverse Events
Immediate Group Delay Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/59 (0%) 0/59 (0%)
Other (Not Including Serious) Adverse Events
Immediate Group Delay Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 13/59 (22%) 10/59 (16.9%)
Musculoskeletal and connective tissue disorders
Muscle pain 10/59 (16.9%) 9/59 (15.3%)
Ligament sprain 3/59 (5.1%) 1/59 (1.7%)

Limitations/Caveats

A limitation is the inclusion of only individuals with rheumatoid arthritis and systemic lupus erythematosus. We focused on these 2 diseases because of feasibility for recruitment in our community. The findings, however, are not generalizable to people with other types of inflammatory arthritis. Furthermore, the results may not be generalizable to men because 89% of the participants were women.

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Linda Li
Organization University of British Columbia
Phone 604-207-4020
Email lli@arthritisresearch.ca
Responsible Party:
Linda Li, Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT02554474
Other Study ID Numbers:
  • H15-01843
First Posted:
Sep 18, 2015
Last Update Posted:
Jun 21, 2022
Last Verified:
May 1, 2022